# EDGAR Filing Document

**Accession Number:** 0001790169
**File Stem:** 0001062993-25-013470
**Filing Date:** 2025-8
**Character Count:** 12704
**Document Hash:** 493e87e2c06cee6462c028b7fe59a579
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001062993-25-013470.hdr.sgml**: 20250804

**ACCESSION NUMBER**: 0001062993-25-013470

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 16

**CONFORMED PERIOD OF REPORT**: 20250804

**ITEM INFORMATION**: Material Modifications to Rights of Security Holders

**ITEM INFORMATION**: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250804

**DATE AS OF CHANGE**: 20250804

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Flora Growth Corp.
- **CENTRAL INDEX KEY:** 0001790169
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A6
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40397
- **FILM NUMBER:** 251178062

**BUSINESS ADDRESS:**
- **STREET 1:** 3230 W. COMMERCIAL BOULEVARD
- **STREET 2:** SUITE 180
- **CITY:** FORT LAUDERDALE
- **STATE:** FL
- **ZIP:** 33309
- **BUSINESS PHONE:** 416-861-2267

**MAIL ADDRESS:**
- **STREET 1:** 3230 W. COMMERCIAL BOULEVARD
- **STREET 2:** SUITE 180
- **CITY:** FORT LAUDERDALE
- **STATE:** FL
- **ZIP:** 33309

?xml version='1.0' encoding='ASCII'? Flora Growth Corp.: Form 8-K - Filed by newsfilecorp.com

------

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

Washington, D.C. 20549

**___________________________**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported):  **<u>August 4, 2025</u>**

**<u>FLORA GROWTH CORP.</u>**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
|  **<u>Ontario</u>** |  **<u>001-40397</u>** | **<u>Not Applicable</u>** |
| (State or other jurisdiction | (Commission | (IRS Employer |
| of incorporation) | File Number) | Identification No.) |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **3230 W. Commercial Boulevard, Suite 180 <u>Fort Lauderdale, Florida, United States 33309</u>** (Address of principal executive offices) (ZIP Code)

Registrant's telephone number, including area code: **<u>(954) 842-4989</u>**

**<u>Not Applicable</u>**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbols** | **Name of each exchange on which registered** |
| Common Shares, no par value | FLGC | NASDAQ Capital Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b -2 of this chapter).

Emerging growth company ☑

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 3.03 Material Modification to Rights of Security Holders**

On August 4, 2025, Flora Growth Corp., a corporation organized under the laws of the Province of Ontario (the "<u>Company</u>"), effected a 1-for-39 share consolidation (the "Share Consolidation") of the Company's issued and outstanding common shares, no par value (the "Common Shares") by the filing of Articles of Amendment to the Company's amended and restated Articles of Incorporation (the "Articles of Amendment") with the Ontario Ministry of Public and Business Service Delivery and Procurement. The Share Consolidation became effective at 5:00 p.m. Eastern Time on August 3, 2025. The Company anticipates that the Common Shares will begin to trade on a post-Share Consolidation basis as of the opening of the Nasdaq Capital Market on August 4, 2025.

On June 30, 2025, the Company held its Annual and Special Meeting of Shareholders (the "Annual Meeting"). At the Annual Meeting, the Company's shareholders approved the Share Consolidation at a ratio ranging from 1-for-10 up to a ratio of 1-for-100, such ratio and the implementation and timing of such Share Consolidation to be determined by the Company's board of directors (the "Board") at its sole discretion, if at all, within one year of the date the proposal is approved by shareholders. On July 10, 2025, the Board approved the Share Consolidation at a ratio of 1-for-39 Common Shares.

As a result of the Share Consolidation, every 39 Common Shares issued and outstanding were automatically reclassified into one new Common Share. The Share Consolidation did not modify any rights or preferences of the Common Shares. Proportionate adjustments will be made to the exercise or conversion prices and the number of Common Shares underlying the Company's outstanding equity awards, convertible securities and warrants, as well as to the number of Common Shares issued and issuable under the Company's equity incentive plans. The Common Shares issued pursuant to the Share Consolidation will remain fully paid and non-assessable.

No fractional shares were issued in connection with the Share Consolidation. Any fractional shares resulting from the Share Consolidation were automatically rounded up to the nearest whole Common Share. Ownership percentages did not meaningfully change as a result of rounding down the fractional shares. Similarly, no fractional shares were issued on the exercise of outstanding stock options, awards or rights, except as otherwise expressly specified in the documents governing such stock options, awards or rights.

The foregoing descriptions of the Articles of Amendment does not purport to be complete and is qualified in its entirety by reference to the complete text of the Articles of Amendment, which is filed herewith as Exhibit 3.1 and incorporated herein by reference.

**Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.**

The information set forth in Item 3.03 of this Current Report on Form 8-K with respect to the Articles of Amendment is incorporated by reference into this Item 5.03.

**Item 9.01 Financial Statements and Exhibits.**

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| [3.1](exhibit3-1.htm) | [Articles of Amendment, filed August 3, 2025](exhibit3-1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **FLORA GROWTH CORP.** | **FLORA GROWTH CORP.** |
| Date: August 4, 2025 | By: | */s/ Clifford Starke* |
|  | Name: | Clifford Starke |
|  | Title: | Chief Executive Officer |

---

------

## Exhibit 3.1

------

---

| | |
|:---|:---|
| ![](exhibit3-1xu001.jpg) | **Articles of Amendment**<br>*Business Corporations Act* |

---

**Instructions**

**For questions or more information to complete this form, please refer to the instruction page.**

Fields marked with an asterisk (\*) are mandatory.

**1. Corporation Information**

Corporation Name \*

FLORA GROWTH CORP.

---

| | |
|:---|:---|
| Ontario Corporation Number (OCN) \* | Company Key \* |
| 0002685552 | 324722453 |
| Official Email Address \* |  |
| csdworkrequests@foglers.com |  |
| **2. Contact Information** |  |

---

Please provide the following information for the person we should contact regarding this filing. This person will receive official documents or notices and correspondence related to this filing. By proceeding with this filing, you are confirming that you have been duly authorized to do so.

---

| | | | | |
|:---|:---|:---|:---|:---|
| First Name \* |  | Middle Name | Last Name \* | Last Name \* |
| Melissa |  |  | Sturges | Sturges |
| Telephone Country Code | Telephone Number \* | Telephone Number \* |  | Extension |
|  | 289-816-0062 |  |  |  |
| Email Address \* |  |  |  |  |
| msturges@foglers.com |  |  |  |  |

---

**3. Proposed New Corporation Name (if applicable)**

Complete this section only if you are changing the corporation name

If you are changing the corporation name, you can either propose a new name or request a number name. If you propose a new name for the corporation, you need a Nuans report for the proposed name. If your corporation has a number name, you must not select the option for a number name, unless you are changing only the legal element.

Will this corporation have a number name ? ☐ Yes ☐ No

**4. Number of Director(s) (if applicable)**

Complete this section only if you are changing the number of directors

Please specify the number of directors for your Corporation

☐ Fixed Number ☐ Minimum/Maximum

**5. Shares and Provisions (if applicable)** (Maximum is 900,000 characters per text box. To activate the toolbar press "Ctrl + E")

Complete this section only if you are amending the Shares and Provisions

**Description of Changes to Classes of Shares**

The corporation amends the Description of Classes of Shares as follows (please be specific):

Enter the Text

The articles of the Corporation are amended by consolidating the issued and outstanding common shares of the Corporation on the basis of thirty-nine (39) pre-consolidation common shares to one (1) post- consolidation common share; provided that, if as a result of the consolidation, a holder of common shares would otherwise be entitled to a fraction of a common share, the number of post-consolidation common shares issuable to such shareholder shall be rounded down to the next lesser whole number of common shares.

5261E (2023/05)© King's Printer for Ontario, 2023 Disponible en français Page 1 of 3

------

**Description of Changes to Rights, Privileges, Restrictions and Conditions**

The corporation amends the Rights, Privileges, Restrictions and Conditions as follows (please be specific):

Enter the Text

**Description of Changes to Restrictions on Share Transfers**

The corporation amends the Restrictions on Share Transfers as follows (please be specific):

Enter the Text

**Description of Changes to Restrictions on Business or Powers**

The corporation amends the Restrictions on Business or Powers as follows (please be specific):

Enter the Text

**Description of Changes to Other Provisions**

The corporation amends the Other Provisions as follows (please be specific):

Enter the Text

**6. Authorization**

☑ \* I, Melissa Sturges

confirm that:

• This form has been signed by the required person.

• This amendment has been duly authorized as required by sections 168 and 170 (as applicable) of the Business Corporations Act.

The resolution authorizing the amendment was approved by the shareholders/directors (as applicable) of the corporation on \*<br>June 30, 2025 <br> Requested Date for Amendment \*<br>August 3, 2025

5261E (2023/05) Page 2 of 3

------

**Caution** - The Act sets out penalties, including fines, for submitting false or misleading information.

**Required Signature**

Name Position Signature <br> <u>Dany Vaiman</u> <u>Chief Financial Officer</u> <u>signed</u>

5261E (2023/05) Page 3 of 3

------